DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 1990--------------------------------------------------
       NEPAD and Ocrevus
       By: agate Date: February 19, 2018, 11:47 am
       ---------------------------------------------------------
       This article is mainly pharma company promotion for Ocrevus but
       includes a discussion of a new standard being used to assess MS
       disease progression, NEPAD (no evidence of progression or active
       disease). From Multiple Sclerosis News Today, February 19, 2018:
  HTML https://multiplesclerosisnewstoday.com/2018/02/19/ocrevus-data-actrims-2018-reinforces-benefit-rrms-ppms-genetech-garren-interview/
       *****************************************************